- Trials with a EudraCT protocol (199)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
199 result(s) found for: Positive psychology.
Displaying page 1 of 10.
| EudraCT Number: 2011-005205-71 | Sponsor Protocol Number: FCE2011 | Start Date*: 2012-04-24 |
| Sponsor Name:Leiden University [...] | ||
| Full Title: The effect of fludrocortisone on emotional information processing in healthy volunteers | ||
| Medical condition: None. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005352-25 | Sponsor Protocol Number: ML11283 | Start Date*: 2015-08-07 |
| Sponsor Name:KU Leuven | ||
| Full Title: The effect of oxytocin on the training of attachment-related interpretation bias | ||
| Medical condition: General population children (ages 8 - 13 years old) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-018064-95 | Sponsor Protocol Number: S52151 | Start Date*: 2012-06-18 |
| Sponsor Name:University of Leuven | ||
| Full Title: Amyloid imaging in late life depression | ||
| Medical condition: Late life depression | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002196-35 | Sponsor Protocol Number: 73520 | Start Date*: 2020-11-16 |
| Sponsor Name:Amsterdam UMC, location VUmc | ||
| Full Title: post-trial access cohort BUmetanide for Developmental DIsorders | ||
| Medical condition: Neurodevelopmental disorders Autism spectrum disorder Attention deficit hyperactivity disorder (ADHD) Learning disorders | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-000098-65 | Sponsor Protocol Number: 09012313 | Start Date*: 2013-09-13 |
| Sponsor Name:University of Tromsø | ||
| Full Title: Treatment of Axial Spondyloarthritis with reduced doses of NSAIDs: Application of pharmacotherapeutic conditioning in clinical practice. | ||
| Medical condition: Axial Spondyloarthritis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000506-11 | Sponsor Protocol Number: Lx-Gf01 | Start Date*: 2017-06-06 |
| Sponsor Name:Limoxifen BV | ||
| Full Title: Proof-of-concept study on treating cognitive side-effects of Tamoxifen with guanfacine in postmenopausal women with E2/Pg receptor-positive breast cancer. | ||
| Medical condition: Memory loss, attention deficit | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-019897-33 | Sponsor Protocol Number: 2522518514 | Start Date*: 2011-04-14 |
| Sponsor Name:erasmus mc | ||
| Full Title: Selective D1 activation by addition of L-Dopa to antipsychotic treatment in patients with schizophrenia | ||
| Medical condition: patients with psychotic symptoms, diagnosed with schizophrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000163-32 | Sponsor Protocol Number: NorPEPS | Start Date*: 2017-06-29 |
| Sponsor Name:Helse-Bergen HF | ||
| Full Title: The Norwegian Prednisolone in Early Psychosis Study - NorPEPS The role of immune-modulating strategies in the treatment of psychosis | ||
| Medical condition: Schizophrenia, schizophreniphorm disorder, schizoaffective disorder, psychosis NOS. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000309-60 | Sponsor Protocol Number: 120101 | Start Date*: 2016-03-30 | |||||||||||
| Sponsor Name:Göteborgs universitet | |||||||||||||
| Full Title: Biochemical and neuropsychological effects on Premenstrual Dysphoric Disorder after acute administration of escitalopram | |||||||||||||
| Medical condition: Premenstrual Dysphoric Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-002386-18 | Sponsor Protocol Number: 11-185/CAIAC | Start Date*: 2016-03-15 |
| Sponsor Name:RWTH Aachen Clinical Trials Center Aachen (CTC-A) | ||
| Full Title: Network connectivity and inhibitory control under atomoxetin challenge - A pharamacological "resting state" and "inhibitory task" fMRI study in patients with ADHD | ||
| Medical condition: Patients with Attention-Deficit/Hyperactivity Disorders (ADHD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-004884-38 | Sponsor Protocol Number: FER-LOX-2016-01 | Start Date*: 2017-09-13 |
| Sponsor Name:Vall d'Hebron University Hospital | ||
| Full Title: Prospective naturalistic clinical trail with loxapine in agitated patients with personality disorder | ||
| Medical condition: Acute pre/agitated patients with personality disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003529-41 | Sponsor Protocol Number: ABR58805 | Start Date*: 2017-02-22 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: CANGLIA: Endocannabinoid control of microglia activation as a new therapeutic target in the treatment of schizophrenia | ||
| Medical condition: Schizophrenia patients | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002070-23 | Sponsor Protocol Number: EEGrofl | Start Date*: 2011-10-12 |
| Sponsor Name:Maastricht University Medical Center | ||
| Full Title: Effects of roflumilast on cognition in healthy adults: a behaviour-EEG study | ||
| Medical condition: None; this proof-of-principle study will examine the cognition enhancing effects of roflumilast in healthy subjects | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001217-25 | Sponsor Protocol Number: 2016-001217-25 | Start Date*: 2016-09-07 |
| Sponsor Name:Uppsala University | ||
| Full Title: Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) | ||
| Medical condition: Premenstrual Dysphoric Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003128-19 | Sponsor Protocol Number: BiCS2019 | Start Date*: 2019-11-27 | |||||||||||
| Sponsor Name:Psykiatrisk Center Glostrup | |||||||||||||
| Full Title: Biomarkers in Clozapine-responding Schizophrenia | |||||||||||||
| Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-000834-36 | Sponsor Protocol Number: 43806 | Start Date*: 2013-09-26 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia. | ||
| Medical condition: Schizophrenia, schizoaffective or schizophreniform disorder (DSM-IV 295.*) or psychosis NOS (not otherwise specified) (298.9) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-001582-12 | Sponsor Protocol Number: 4 | Start Date*: 2023-03-01 |
| Sponsor Name:Consorcio Centro de Investigacion Biomedica en Red (CIBER) | ||
| Full Title: Open, multicenter, randomized clinical trial to evaluate the efficacy and safety of aripiprazole vs paliperidone / risperidone using multi-omics data in patients with a first psychotic episode. | ||
| Medical condition: First episode SZ-spectrum individuals | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003573-97 | Sponsor Protocol Number: PSIDER | Start Date*: 2020-08-27 | |||||||||||
| Sponsor Name:King's College London [...] | |||||||||||||
| Full Title: A randomised, placebo controlled trial of psilocybin in treatment resistant depression: A feasibility study | |||||||||||||
| Medical condition: Major depressive disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-003008-53 | Sponsor Protocol Number: 80836009820016 | Start Date*: 2014-12-10 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: Clonidine Augmentation Therapy in Schizophrenia | ||
| Medical condition: Schizophrenia, schizophreniform disorder, schizoaffective disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-000415-25 | Sponsor Protocol Number: NAS-S-01 | Start Date*: 2013-11-07 | ||||||||||||||||
| Sponsor Name:Clinirx Tangent Research | ||||||||||||||||||
| Full Title: A randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of Naproxen, Simvastatin and their combination, compared to placebo as add-on to anti-psychotics in the trea... | ||||||||||||||||||
| Medical condition: schizophrenia and schizoaffective disorder. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: RO (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.